Transverse Myelitis Trial, Recruiting NCT06147258 Sponsor: University of Alabama at Birmingham Condition: Transverse Myelitis
Back to Transverse Myelitis

Transverse Myelitis Trial, Recruiting

NCT06147258
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a spinal cord injury (either from an accident/injury or a medical condition) that has caused weakness in your arms or legs
  • You are over 18 years old
  • You have access to the internet and a computer or smartphone that can be used for video calls
  • You can read, write, and communicate well enough in English to fill in questionnaires and understand the program content

Who may not be able to join:

  • You have severe cognitive or thinking difficulties that would prevent you from learning online or completing the study assessments
  • You are currently experiencing thoughts of suicide that require emergency care
  • You have been regularly attending therapy/counselling sessions within the last 6 months
  • You are currently in, or planning to join, another psychological therapy program or clinical trial during this study that could affect the results
  • Your spinal cord condition was present from birth (for example, spina bifida)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hon Yuen, PhD, University of Alabama at Birmingham

Phone: 205-934-6301

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 May 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Grief and Loss Scale; Impact of Events Scale; Emotional Distress - Depression; Perceived Stress Scale (PSS); Sleep Disturbance; Sleep Impact; Meaning and Purpose; Self-Efficacy for Managing Chronic Conditions - Managing Emotions; Ability to Participate in Social Roles and Activities; Satisfaction with Social Roles and Activities; Connor-Davidson Resilience Scale; Cortisol level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov